News
Latest News
SickKids and MyOme Enter Licensing and Research Agreement to Advance DNA Methylation Signatures
IN THE PRESS SickKids and MyOme Enter Licensing and Research Agreement To Advance DNA Methylation Signatures The Hospital for Sick Children (SickKids) and its [...]
Winners of the 10th Annual PoP Competition
FUNDING ANNOUNCEMENT SickKids Innovations Take the Stage in the 2026 Proof of Principle Grant Competition The SickKids Industry Partnerships & Commercialization (IP&C) office is [...]
New Machine Learning Approach Could Transform the Future of Neurodevelopmental Disorder Diagnostics
LATEST PUBLICATIONS New Machine Learning Approach Could Transform the Future of Neurodevelopmental Disorder Diagnostics As advances in genome sequencing continue to expand the reach of prenatal genetic [...]
Two SickKids Innovations Selected for Second Year of the Technology Advancement Program
FUNDING ANNOUNCEMENT Two SickKids Innovations Selected for Second Year of the Technology Advancement Program Industry Partnerships & Commercialization (IP&C) is pleased to announce the [...]
SickKids and VUS Genetics Collaborate to Advance Gene Variant Testing with SickKids-Developed Genomics Platform
IN THE PRESS SickKids and VUS Genetics Collaborate to Advance Gene Variant Testing with SickKids-Developed Genomics Platform The Hospital for Sick Children (SickKids) and [...]
Measuring the Real-World Impact of Accessible Genomic Testing with the SickKids C-GUIDE™
IN THE PRESS Measuring the Real-World Impact of Accessible Genomic Testing with the SickKids C-GUIDE™ Children living with rare genetic diseases often spend years [...]
SickKids IP&C is Now Hiring: Senior Manager, Digital Innovations
JOB OPPORTUNITY SickKids IP&C is Now Hiring: Senior Manager, Digital Innovations Technology is rapidly transforming the way health care is delivered, from AI-powered diagnostic tools [...]
Targeted Anti-Toxin Therapeutic Shows Major Promise Against C. difficile in SickKids-Led Study
LATEST PUBLICATION Targeted Anti-Toxin Therapeutic Shows Major Promise Against C. difficile in SickKids-Led Study Clostridioides difficile (C. diff) is a leading cause of hospital-acquired [...]
Mapping Malaria Transmission: Advancements Towards Precision Medicine
LATEST PUBLICATION Mapping Malaria Transmission: Advancements Towards Precision Medicine Through the Industry Partnerships & Commercialization (IP&C) Office, The Hospital for Sick Children (SickKids) empowers its researchers to [...]
SickKids Innovations Take the Stage in the 2025 Proof of Principle Grant Competition
FUNDING ANNOUNCEMENT SickKids Innovations Take the Stage in the 2025 Proof of Principle Grant Competition The SickKids Industry Partnerships & Commercialization (IP&C) office is [...]















